Primary Immunodeficiencies
300 genetic defects identified
~1/500 incidence
Varying severity
Can affect any immune pathway or cell type
Opportunistic infections
Pattern of infections depends on defect
Usually detected early in life
Challenges in diagnosis:
Masked by maternal immunity
Requires tracking vaccine responses & infection history
Often takes years to identify specific defects
Push for neonatal screening in severe cases
Failures in immune development or processes
Affect different immune pathways or cell types
Many mutations are recessive or X-linked
Difficult to identify until recent advances
Failures in immune system control mechanisms
Failure in Central Tolerance → Autoimmunity
Failure in Treg development → Uncontrolled immune responses
Defects in innate immune functions:
Chronic Granulomatous Disease (CGD): Failure in macrophage effector mechanisms
Leukocyte Adhesion Deficiencies (LADs): Failure in leukocyte recruitment cascade
T cell deficiencies impact antibody responses
Severe Combined Immunodeficiencies (SCID):
Complete absence of functional T cells
Often failure in lymphoid development or hematopoiesis
Multiple genetic mutations, categorized into five broad types
Phenotypic differences (e.g., T-B-NK+, T-B+NK-)
Defects in immune receptor recombination
Mutations in RAG1, RAG2, Artemis
Defects in cytokine signaling pathways
Mutations in common γ chain, JAK3
T- NKint B+ (mouse: B-)
Defects in TCR signaling
Mutations in the CD3 signaling complex
David Vetter (1971-1984)
X-linked SCID (xSCID): Common γ chain defect
Lived 12 years in isolation
Bone marrow transplant attempted → died from infection
Specific Absence of B Cells
X-linked Agammaglobulinemia
Defects in T Cell Help
Loss of function of CD40 or CD40L
Limited class switching
Replacing missing immune components:
IVIG for antibody deficiencies
Hematopoietic stem cell transplant (SCID) (performed early in life)
Gene Therapy Approaches:
Common γ chain: Some success (20 cases), risk of leukemia
ADA (Adenosine Deaminase Deficiency): Good success (>24 cases)
Naturally occurring or genetically engineered
Humanized mouse models
Recipients of human immune cells